Seqens
Seqens, officially known as Seqens S.A., is a leading player in the pharmaceutical and fine chemicals industry, headquartered in France. Established in 2017, Seqens has rapidly expanded its operations across Europe, North America, and Asia, positioning itself as a key partner for major pharmaceutical companies. The company specialises in the development and manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates, offering unique solutions that cater to the evolving needs of the market. With a strong focus on innovation and sustainability, Seqens has achieved significant milestones, including the establishment of several state-of-the-art production facilities. Recognised for its commitment to quality and regulatory compliance, Seqens has solidified its market position, serving a diverse clientele and contributing to advancements in healthcare. Its dedication to excellence and customer satisfaction sets Seqens apart in a competitive landscape.
DitchCarbon Score
How does Seqens's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Seqens's score of 46 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Seqens's reported carbon emissions
In 2024, Seqens reported total carbon emissions of approximately 68,826,000 kg CO2e for Scope 1 and about 227,059,000 kg CO2e for Scope 2, resulting in a combined total of approximately 295,885,000 kg CO2e for these scopes. This marks a slight increase in Scope 1 emissions from 66,019,000 kg CO2e in 2023, while Scope 2 emissions decreased from 227,881,000 kg CO2e in the same year. Seqens has set ambitious climate commitments, aiming for a significant reduction in greenhouse gas emissions. The company targets a 46.2% absolute reduction in Scope 1 and 2 emissions by 2031, using 2021 as the baseline year. Additionally, Seqens aims to reduce its Scope 3 emissions by 27.5% within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support the global effort to limit temperature rise to 1.5°C. Furthermore, Seqens is committed to reducing energy consumption per tonne of product manufactured by 10% between 2021 and 2025 for both Scope 1 and Scope 2 emissions. The company has also set a long-term goal to reduce CO2e emissions per tonne of product manufactured by 45% from 2011 to 2025 across Scopes 1 and 2. Overall, Seqens is actively working towards substantial emissions reductions, demonstrating its commitment to sustainability and climate action within the chemicals sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Seqens is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
